Halozyme Therapeutics Inc logo

Halozyme Therapeutics Inc

FRA:RV7 (USA)   Ordinary Shares
€ 40.96 (-1.54%) May 20
18.58
P/B:
32.17
Market Cap:
€ 5.26B ($ 5.71B)
Enterprise V:
€ 6.22B ($ 6.75B)
Volume:
-
Avg Vol (2M):
53.00
Also Trade In:

Halozyme Therapeutics Inc (FRA:RV7) Stock News, Headlines & Updates

Halozyme Therapeutics Inc Stock News from GuruFocus

Total 11
  • 1
Total 11
  • 1
Show
Entries

Headlines

Total 0
  • 1
No recent news